Across all tumor types and cutoffs, patients identified as PD-L1–positive by both manual and AI-powered scoring demonstrated improved associations with survival compared with patients identified as PD-L1–negative by both manual and AI-powered assessment. This evidence concerns the gene CD274 and neoplasm.